B+
Bull case
0%
Probability
Target price
$30.00
Analysis reference price unavailable
Analysis 2026-09-27 · RankAlpha Sentiment Codex
VOR
Vor BiopharmaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Completed UPSTREAM MG enrollment reduces one execution uncertainty, while the expected first-half 2027 readout offers substantial upside if global efficacy and safety support registration. Vor reported $466.1 million of June cash and investments plus $48.4 million of July ATM proceeds, with projected runway into early 2029.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -3.0.
What can break
Cash-runway guidance depends on development spending and assumptions; additional issuance could dilute shareholders.
Momentum
41
Value
41
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $16.00 · Bull $30.00 · Bear $7.00Analysis 2026-09-27; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-27 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $39.00
Why
Momentum41 · Δ7d +10.7
Value41 · Δ7d -0.1
Sentiment46 · Δ7d -3.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -3.0.
Contradictions & invalidation
- • Cash-runway guidance depends on development spending and assumptions; additional issuance could dilute shareholders.
- • Chinese telitacicept approvals do not establish approval or commercial uptake in Vor’s intended markets outside China.
- • The global Phase 3 result remains unproven, SjD has no announced readout date, and launching oMG could raise spending.
Catalyst clock
2027-06-30
UPSTREAM MG Phase 3 topline results
Lead driver: Sentiment · See AI snapshot
Momentum
41
8% active weight
Current posture
7d trendImproving
Δ7d
+10.7
Δ21d
+1.8
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.3
Sentiment
46
45% active weight
Current posture
7d trendSoftening
Δ7d
-3.0
Δ21d
-6.8
Why this grade
Composite grade D. Momentum 41.3 / Value 40.6 / Sentiment 45.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-27. Scenario method
Most likely
B
Base case
1%
Probability
Target price
$16.00
Analysis reference price unavailable
Analysis 2026-09-27 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$7.00
Analysis reference price unavailable
Analysis 2026-09-27 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$1.16B
Beta
2.03
Shares Out
59.16M
P/E (TTM) · Derived
-0.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.95
Rev YoY
-
EPS YoY
-99.5%
Gross Margin
-
Op Margin
-
Net Debt
-$452.21M
Current Ratio
19.15
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data